StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTI) stock

KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.04−0.01 (-20.00%)

Close on Nov 9, 2026Market cap $1.16KP/E –Yield –

Karyopharm Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Karyopharm Therapeutics's price to sales ratio was 0.0× on Nov 9, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 5.7×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 9, 20260.0×−0.4
2025Dec 31, 20250.4×−0.1
2024Dec 31, 20240.6×−0.1
2023Dec 29, 20230.7×−0.4
2022Dec 30, 20221.1×−3.0
2021Dec 31, 20214.1×−8.4
2020Dec 31, 202012.5×−39.8
2019Dec 31, 201952.3×+34.3
2018Dec 31, 201818.0×−208.8
2014Jan 31, 2014226.7×+77.9
2013Dec 31, 2013148.9×–

More Karyopharm Therapeutics figures

See a number that looks wrong?